Back to Results
First PageMeta Content
Experimental cancer treatments / Oncolytic virus / Immunology / Medical research / Immunotherapy / Gene therapy / Reolysin / Medicine / Biology / Viruses


FINAL FOR DISTRIBUTION PSIOXUS THERAPEUTICS RAISES A £25M SERIES C INVESTMENT TO PROGRESS ONCOLYTIC VIRUS PLUS CHECKPOINT INHIBITOR COMBINATION STUDY IN METASTATIC COLORECTAL CANCER OXFORD, UK – 19 May 2015 – PsiOxu
Add to Reading List

Document Date: 2015-05-19 03:49:40


Open Document

File Size: 246,17 KB

Share Result on Facebook
UPDATE